At the Crossroads of the Microbiome, Metabolism & Glycoscience

Friday, April 29, 2022
09:00 AM-05:00 PM(EST)
An NIH Videocast (virtual)
NIGMS,
Bethesda, MD - 20892

Max.Capacity: 1000 No Participants

Agenda:

Session I

9- 12:00p.m.

Speakers 

09:00a.m., Dr. Victor Nizet, University of California San Diego 

                             Glycobiology of Platelet-Mediated Immunity in Bacterial Sepsis

09:20a.m., Dr. Laura Kiessling, Massachusetts Institute of Technology

                             Lectins as probes of the human microbiome

09:40a.m., Dr. Samantha King, Nationwide Children's Hospital, The Ohio State University College of Medicine

                             Novel streptococcal glycan binding adhesins   

10:00a.m., Dr. Emily P. Balskus, Harvard Chemistry and Chemical Biology 

                             Enzyme discovery in the human microbiome 

10:20a.m., Dr. Lorenzo Leggio, National Institute on Drug Abuse & National Institute on Alcohol Abuse and Alcoholism, NIH

                             Gut microbiome in alcohol use disorder 

10:40a.m., Dr. Mario Feldman, Washington University School of Medicine, St. Louis 

                              Bacterial vesicles and the degradation of polysaccharides in the gut

11:00a.m., Dr. Fikri Avci, University of Georgia 

                             Glycan mediated immunoregulation in health and disease

11:20a.m., Dr. Drew Kiraly, Mount Sinai University  

                   Manipulations of gut microbiome diversity alter behavioral and neurobiological response to opioids                             

11:40a.m.; Dr. Stefan Ruhl, University at Buffalo School of Dental Medicine 

                            Straight from the mouth ¿ natural glycan-binding tools harnessed from the oral microbiome

12:00p.m., Dr. Michael Fischbach, Stanford University 

                             Small molecules from the human microbiota

12:20p.m.,  Lunch 

05:00p.m., Adjourn 

Session II 

01:00- 5:00p.m. 

Speakers 

01:00p.m., Dr. Richard Cummings, Beth Israel Deaconess Hospital, Harvard Medical School 

                             Interrelationships of the Intestinal Glycome, Microbiome and Immunity

01:20p.m., Dr. Mariana Xavier Byndloss, Vanderbilt University Medical Center

                             Disruption of microbiota and intestinal epithelial interactions as a key driver of non-communicable diseases

01:40p.m., Dr. Christine Szymanski, University of Georgia

                             New paradigms for Campylobacter jejuni survival in the gut

02:00p.m., Dr. Amanda Lewis, University of California San Diego 

                             Resident microbes shape the vaginal epithelial glycan landscape

02:20p.m., Dr. Mohamed Abdel-Mohsen, Wistar Institute

                             Glycomic modulation of the gut microbiome during viral infections

02:40p.m., Dr. Seth Rakoff-Nahoum, Boston Children's Hospital, Harvard Medical School   

                           Glycan-Metabolite Emergent Properties in the Gut Micriobiome

03:00p.m., Dr. Katharina Ribbeck, Massachusetts Institute of Technology 

                             Partners in slime: How mucus regulates microbial virulence

03:20p.m., Dr. Sean Stowell, Brigham and Women¿s, Harvard Medical School

                             Discovering Determinants of Naturally Occurring Antibody Repertoires Using Microbial Glycan Microarrays

03:40p.m., Dr. Steven Townsend, Vanderbilt University  

                             Human Milk Oligosaccharides as Microbiome Modulators

04:00p.m., Dr. Nadine Samara, National Institute of Dental and Craniofacial Research, NIH 

                             The diverse substrate specificities of mucin-type O-glycosyltransferases 

04:20p.m., Dr. Catherine Grimes, University of Delaware   

                             Keeping track of the microbiome¿s peptidoglycan

04:40p.m., Open Discussion